BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases ...
UD researchers develop a first-of-its-kind conductive hydrogel that can switch between liquid and solid states ...
Sjögren's syndrome may lead to dental caries, periodontal disease, denture intolerance, candidosis and dysphagia. This study evaluated the use of a hydrogel polymer buccal insert as a controlled ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback